Groupe Berkem Acquires i.Bioceuticals from International Nutrition Company (INC)
February 16, 2023
Groupe Berkem has acquired i.Bioceuticals, the exclusive North American distributor of OPC and pine bark extracts from Dutch supplier International Nutrition Company (INC). The cash transaction transfers i.Bioceuticals' Massachusetts-based team to Groupe Berkem as the Group expands its bio-based health, beauty and nutraceutical offering and strengthens its footprint in North America.
- Buyers
- Groupe Berkem
- Targets
- i.Bioceuticals, Inc.
- Sellers
- International Nutrition Company (INC)
- Industry
- Food & Beverage
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Groupe Berkem Acquires Biopress
April 3, 2023
Food & Beverage
Groupe Berkem completed the acquisition of Biopress, a French producer of 100% natural vegetable oils and plant proteins, effective April 1, 2023. The deal—carried out by Berkem Développement, a wholly owned subsidiary of Groupe Berkem—was paid in cash and funded from equity; Biopress's 11 employees joined the Group and the acquisition expands Berkem's local sourcing, processing capacity and access to agri-food, cosmetics, nutraceutical and industrial markets.
-
Ergon Capital Acquires Majority Stake in Millbo–BioNaturals Group
December 16, 2020
Food & Beverage
Ergon Capital Partners IV SCSP has closed the acquisition of a majority stake in Millbo, BioNaturals International and BioNaturals Europe (together "Millbo–BioNaturals"), creating a global supplier of natural, clean-label bakery ingredients. The sellers (including Millbo/Boggiani family and other shareholders) will reinvest alongside Ergon, and the investment is intended to accelerate growth through geographic expansion, product cross-selling and a buy-&-build strategy.
-
IK Partners Acquires Majority Stake in BIOBank
May 29, 2024
Medical Devices
IK Partners (via its IK Small Cap III fund) has agreed to acquire a majority stake in French tissue bank BIOBank from Verto Growth, Capital Croissance and management, who will reinvest. BIOBank, headquartered in Lieusaint, France, is a leading processor and distributor of bone allografts for orthopaedic, spine, dental and cranio‑maxillofacial surgery; IK plans to support market-share gains in France, accelerate international expansion and pursue a buy‑and‑build strategy.
-
Optibrium Acquires BioPharmics LLC
August 31, 2023
Software
Optibrium, a Cambridge-based developer of software and AI solutions for small-molecule drug discovery, has acquired BioPharmics LLC to expand its 3D ligand- and structure-based drug design and visualisation capabilities. The acquisition brings BioPharmics' algorithms and products (including ForceGen, Surflex-Dock, eSim and QuanSA) and its founding scientists into Optibrium's StarDrop platform to strengthen 3D modelling, docking and binding-affinity prediction functionality.
-
Biobest Group Acquires BioWorks, Inc.
July 10, 2023
Agriculture
Biobest Group has completed its acquisition of BioWorks, Inc., a Victor, New York-based manufacturer and marketer of biopesticides. The deal expands Biobest's biopesticide portfolio and establishes BioWorks' Victor facility as the group's North American manufacturing and marketing hub for biopesticides.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.